The latest closing stock price for Intra-Cellular Therapies as of September 18, 2024 is 74.70.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $3,980 today, roughly 4 times their original investment - a 15.71% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 80.84 on July 25, 2024.
The Intra-Cellular Therapies 52-week high stock price is 84.89, which is 13.6% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 45.50, which is 39.1% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 67.14.
An investor who bought $1,000 worth of Intra-Cellular Therapies stock at the IPO in 2014 would have $3,980 today, roughly 4 times their original investment - a 15.71% compound annual growth rate over 11 years.
The all-time high Intra-Cellular Therapies stock closing price was 80.84 on July 25, 2024.
The Intra-Cellular Therapies 52-week high stock price is 84.89, which is 13.6% above the current share price.
The Intra-Cellular Therapies 52-week low stock price is 45.50, which is 39.1% below the current share price.
The average Intra-Cellular Therapies stock price for the last 52 weeks is 67.14.